title: Survivorship: immunizations and prevention of infections, version 2.2014.
abstract: Cancer survivors are at an elevated risk for infection because of immune suppression associated with prior cancer treatments, and they are at increased risk of complications from vaccine-preventable diseases. This section of the NCCN Guidelines for Survivorship provides recommendations for the prevention of infections in survivors through education, antimicrobial prophylaxis, and the judicious use of vaccines. These guidelines provide information about travel and gardening precautions and safe pet care/avoidance of zoonosis, and include detailed recommendations regarding vaccinations that should be considered and encouraged in cancer and transplant survivors.
authors.forename: Crystal S
authors.initials: CS
authors.lastname: Denlinger
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Ligibel
authors.forename: Madhuri
authors.initials: M
authors.lastname: Are
authors.forename: K Scott
authors.initials: KS
authors.lastname: Baker
authors.forename: Wendy
authors.initials: W
authors.lastname: Demark-Wahnefried
authors.forename: Don
authors.initials: D
authors.lastname: Dizon
authors.forename: Debra L
authors.initials: DL
authors.lastname: Friedman
authors.forename: Mindy
authors.initials: M
authors.lastname: Goldman
authors.forename: Lee
authors.initials: L
authors.lastname: Jones
authors.forename: Allison
authors.initials: A
authors.lastname: King
authors.forename: Grace H
authors.initials: GH
authors.lastname: Ku
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Kvale
authors.forename: Terry S
authors.initials: TS
authors.lastname: Langbaum
authors.forename: Kristin
authors.initials: K
authors.lastname: Leonardi-Warren
authors.forename: Mary S
authors.initials: MS
authors.lastname: McCabe
authors.forename: Michelle
authors.initials: M
authors.lastname: Melisko
authors.forename: Jose G
authors.initials: JG
authors.lastname: Montoya
authors.forename: Kathi
authors.initials: K
authors.lastname: Mooney
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Morgan
authors.forename: Javid J
authors.initials: JJ
authors.lastname: Moslehi
authors.forename: Tracey
authors.initials: T
authors.lastname: O'Connor
authors.forename: Linda
authors.initials: L
authors.lastname: Overholser
authors.forename: Electra D
authors.initials: ED
authors.lastname: Paskett
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Peppercorn
authors.forename: Muhammad
authors.initials: M
authors.lastname: Raza
authors.forename: M Alma
authors.initials: MA
authors.lastname: Rodriguez
authors.forename: Karen L
authors.initials: KL
authors.lastname: Syrjala
authors.forename: Susan G
authors.initials: SG
authors.lastname: Urba
authors.forename: Mark T
authors.initials: MT
authors.lastname: Wakabayashi
authors.forename: Phyllis
authors.initials: P
authors.lastname: Zee
authors.forename: Nicole R
authors.initials: NR
authors.lastname: McMillian
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Freedman-Cass
mesh_terms: D003141:Communicable Diseases / Q000139:chemically induced / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D017408:Guidelines as Topic; D006801:Humans; D007114:Immunization; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D018570:Risk Assessment; D015996:Survival Rate; D017741:Survivors; D014611:Vaccination
references.citation: MMWR Recomm Rep. 2011 Jan 28;60(2):1-64
references.pmid: 21293327
references.citation: Mycopathologia. 2009 Dec;168(6):329-37
references.pmid: 19859825
references.citation: Top Companion Anim Med. 2009 Nov;24(4):164-74
references.pmid: 19945084
references.citation: Ann Intern Med. 2013 Feb 5;158(3):191-9
references.pmid: 23358660
references.citation: MMWR Surveill Summ. 2012 Jan 20;61(1):1-23
references.pmid: 22258477
references.citation: J Gen Intern Med. 2009 Apr;24(4):469-74
references.pmid: 19156470
references.citation: MMWR Suppl. 2013 Feb 1;62(1):1
references.pmid: 23364301
references.citation: Cancer. 2009 Dec 15;115(24):5627-36
references.pmid: 19813272
references.citation: Ann Intern Med. 2014 Feb 4;160(3):190
references.pmid: 24658695
references.citation: Infect Dis Clin North Am. 2012 Sep;26(3):609-24
references.pmid: 22963773
references.citation: Clin Infect Dis. 2014 Feb;58(3):309-18
references.pmid: 24421306
references.citation: Clin Infect Dis. 2013 Mar;56(6):861-9
references.pmid: 23175562
references.citation: MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4
references.pmid: 18528318
references.citation: MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9
references.pmid: 23051612
references.citation: J Korean Med Sci. 2012 Jan;27(1):78-83
references.pmid: 22219618
references.citation: MMWR Recomm Rep. 2013 Sep 20;62(RR-07):1-43
references.pmid: 24048214
references.citation: J Am Geriatr Soc. 2012 Nov;60(11):2099-103
references.pmid: 23126598
references.citation: Ann Hematol. 2009 Aug;88(8):761-7
references.pmid: 19083236
references.citation: Biol Blood Marrow Transplant. 2009 Dec;15(12):1538-42
references.pmid: 19896077
references.citation: Can Commun Dis Rep. 2007 Apr 1;33(ACS-4):1-24
references.pmid: 17520776
references.citation: J Am Osteopath Assoc. 2011 Oct;111(10 Suppl 6):S31-3
references.pmid: 22086893
references.citation: Bone Marrow Transplant. 2009 Oct;44(8):521-6
references.pmid: 19861986